Journal of Cardiovascular Pharmacology

Are we finally moving beyond symptom control to truly disease-modifying therapy in hypertrophic cardiomyopathy? pubmed.ncbi.nlm.nih.gov/41696994 @DrMarikoHarper1 #CardioTwitter #HCM #Cardiomyopathy #PrecisionMedicine #HeartHealth

Can antibiotics quietly undermine one of our most trusted cardiovascular therapies? pubmed.ncbi.nlm.nih.gov/41701630 #CardioTwitter #Microbiome #Statins #Antibiotics #PrecisionMedicine

📢 Call for manuscripts for the special review series in Journal of Cardiovascular Pharmacology: Cardiac Aging and Biological Clocks. We welcome high-quality reviews on circadian regulation, clock genes, aging clocks, and chronopharmacology with clear translational and clinical relevance. Submit here: www2.cloud.editorialmanager.com/jcvp/default2.… #Cardiology #CircadianRhythms #Chronopharmacology #Aging #BiologicalClocks #CardioTwitter

Are we entering an era where “all-oral” combination lipid therapy can rival—or even replace—injectable strategies in high-risk patients? pubmed.ncbi.nlm.nih.gov/41770609 @gbiondizoccai #CardioTwitter #Lipidology #ApoB #PreventiveCardiology #ASCVD

Can AI truly overcome the high failure rates and long timelines in cardiovascular drug development—or are we underestimating the challenges? pubmed.ncbi.nlm.nih.gov/41632854 #CardioTwitter #AIinHealthcare #DrugDiscovery #PrecisionMedicine #ClinicalTrials

Can PCSK9 inhibitors finally close the therapeutic gap for Lp(a)-driven cardiovascular risk? pubmed.ncbi.nlm.nih.gov/41677790 #CardioTwitter #LipoproteinA #PCSK9 #Atherosclerosis #PrecisionMedicine

Could the S-enantiomer of amlodipine offer better long-term cardiovascular protection than standard racemic amlodipine in patients with hypertension? pubmed.ncbi.nlm.nih.gov/41661542 #CardioTwitter #Hypertension #CardiovascularOutcomes #Pharmacology #RealWorldEvidence

As triple immune checkpoint regimens move closer to the clinic, are we ready to detect and manage their potential cardiotoxic risks early enough? pubmed.ncbi.nlm.nih.gov/41592248 @istitutotumori #CardioTwitter #CardioOncology #Immunotherapy #CancerResearch #TranslationalScience

Can intraoperative drug removal meaningfully change bleeding risk when urgent cardiac surgery can’t wait for antiplatelet washout? pubmed.ncbi.nlm.nih.gov/41642317 #CardioTwitter #CardiacSurgery #Pharmacokinetics #AntiplateletTherapy #MedicalDevices

Could epigenetic modulation explain the cardioprotection seen with SGLT2 inhibitors? pubmed.ncbi.nlm.nih.gov/41569049 #CardioTwitter #SGLT2i #CardioEpigenetics #HeartFailure #TranslationalResearch

How should real-world muscle safety data shape our confidence in statin alternatives like bempedoic acid? pubmed.ncbi.nlm.nih.gov/41569102 #CardioTwitter #Lipidology #DrugSafety #Pharmacovigilance #RealWorldEvidence

Could a subtle shift in molecular structure unlock stronger vascular therapies? pubmed.ncbi.nlm.nih.gov/41343365 #CardioTwitter #VascularBiology #NitricOxide #Pharmacology #TranslationalScience

Should protamine be routine—or selective—when managing coronary perforation during CTO PCI? pubmed.ncbi.nlm.nih.gov/41568926 @LAzzaliniMD @DrBillLombardi @KateKearney4 @Sant_J_Kumar #CardioTwitter #InterventionalCardiology #CTOPCI #PatientSafety #RealWorldEvidence

Are oral PCSK9 inhibitors the missing link between potent LDL-C lowering and real-world accessibility? pubmed.ncbi.nlm.nih.gov/41468554

🏆 #JCVPTopPosts – Q4 2025 Here are the most impactful posts from @JCVPonline in the last quarter of 2025: 1️⃣ Intrapericardial Bleomycin: A Promising Option for Malignant Pericardial Effusion x.com/JCVPOnline/sta… 2️⃣ Blocking Inflammation to Boost Heart Fitness: Anakinra’s Promise in Heart Failure x.com/JCVPOnline/sta… 3️⃣ Exercise & Resveratrol: Shielding Kidneys and Vessels from Hypertension x.com/JCVPOnline/sta… 📌 Follow #JCVPTopPosts to stay updated on trending cardiovascular pharmacology research! 🔗 Read more: journals.lww.com/cardiovascular… #CardiovascularPharmacology #BiomedicalResearch #ClinicalResearch #CardioTwitter

Can anti-inflammatory therapy like colchicine meaningfully reduce cardiovascular risk, and how comfortable are we with AI helping shape the evidence? pubmed.ncbi.nlm.nih.gov/41406368 #CardioTwitter #CardiovascularResearch #Inflammation #MetaAnalysis #AIinScience

AI-Powered Mega-Meta-Analysis Reveals Hidden Cardiac Remodeling in Preeclampsia pubmed.ncbi.nlm.nih.gov/41252711 #Preeclampsia #CardiacRemodeling #MetaAnalysis #MaternalHealth #AIinMedicine #CardioTwitter

Unlocking a New Shield Against Heart Attack Damage: The Power of sGC pubmed.ncbi.nlm.nih.gov/41082249 #Cardioprotection #IschemiaReperfusion #Mitochondria #OxidativeStress #HeartResearch #CardioTwitter

Can IL-1 Blockade Boost Fitness in Heart Failure at Any Age? pubmed.ncbi.nlm.nih.gov/41071648 #HeartFailure #Inflammation #Anakinra #CardiorespiratoryFitness #IL1Blockade #CardioTwitter

Hypertension vs. Heart Failure Risk: How Cerebral Arterioles Respond Differently pubmed.ncbi.nlm.nih.gov/41144633 @um_pharmacology @uofm_pharmacy @um_radyfhs @manitobaneuro #Hypertension #HeartFailure #Cerebrovascular #VascularBiology #Neurovascular #CardioTwitter